Pacer Advisors
GOSS icon

Pacer Advisors’s Gossamer Bio GOSS Stock Holding History

Pacer Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,059
Closed -$38K – 1465
2021
Q1 		$38K Buy
4,059
+506
+14% +$5.1K ﹤0.01% 1467
2020
Q4 		$34K Buy
3,553
+1,705
+92% +$16.8K ﹤0.01% 1450
2020
Q3 		$23K Buy
+1,848
New +$24.5K ﹤0.01% 1352

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Pacer Advisors's GOSS Position: Q2 2021 in Review

Pacer Advisors sold out of Gossamer Bio (GOSS) in Q2 2021, closing a stake of 4,059 shares — an estimated $38K sold.

Pacer Advisors first reported a position in GOSS in Q3 2020 and held it in 3 quarters. The position peaked at $38K in Q1 2021. 115 funds tracked by Wall St. Rank hold GOSS as of Q2 2021.

  • Pacer Advisors reported no remaining Gossamer Bio position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 4,059 Gossamer Bio shares in Q2 2021, an estimated $38K.
  • Pacer Advisors first reported a position in Gossamer Bio in Q3 2020 and held it in 3 quarters.
  • Pacer Advisors's Gossamer Bio position peaked at $38K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.